How does menopause drug Veoza differ to hormone therapy?
Veoza (fezolinetant) is a new non-hormonal medication approved for treating menopausal vasomotor symptoms like hot flushes. Unlike traditional hormone replacement therapy, it works by blocking specific brain signals in the hypothalamus to regulate body temperature.
Why it matters
It provides a critical alternative for women who cannot use hormone-based treatments due to health conditions or side effects.
<p>Hot flushes and night sweats – collectively called vasomotor symptoms – are among the most common and disruptive symptoms of menopause. They affect almost 40% of women in the lead up to menopause, known as perimenopause.</p> <p><b>By Robyn Brown and Leigh Walker for The Conversation</b></p> <p>Until 2024, treatment options were largely limited to hormone replacement therapy (HRT). HRT is very effective for many women. But some can’t take it because they experience significant side effects or have certain health conditions.</p> <p>Veoza (fezolinetant) is a drug approved specifically for menopausal vasomotor symptoms. Unlike HRT, it doesn’t replace naturally declining hormones.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in